CHAMPIONS ONCOLOGY, INC. Deferred Tax Assets, Operating Loss Carryforwards
CHAMPIONS ONCOLOGY, INC. (CSBR) had Deferred Tax Assets, Operating Loss Carryforwards of $10.96 million as of 2026-04-30, per its 10-K filed 2026-07-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-07-27
- 2026-04-30: Deferred Tax Assets, Operating Loss Carryforwards $10.96M.
- 2025-04-30: Deferred Tax Assets, Operating Loss Carryforwards $8.25M.
- 2024-04-30: Deferred Tax Assets, Operating Loss Carryforwards $9.04M.
- 2023-04-30: Deferred Tax Assets, Operating Loss Carryforwards $9.76M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-04-30 | $10.96M 10-K · filed 2026-07-27 | |
| 2025-04-30 | $8.25M 10-K · filed 2026-07-27 | |
| 2024-04-30 | $9.04M 10-K · filed 2025-07-23 | |
| 2023-04-30 | $9.76M 10-K · filed 2024-07-19 | |
| 2022-04-30 | $11.55M 10-K · filed 2023-07-24 | |
| 2021-04-30 | $11.40M 10-K · filed 2022-07-22 | |
| 2020-04-30 | $11.22M 10-K · filed 2021-07-26 | $11.17M 10-K · filed 2020-07-28 |
| 2019-04-30 | $10.46M 10-K · filed 2020-07-28 | |
| 2018-04-30 | $9.68M 10-K · filed 2019-07-29 | |
| 2017-04-30 | $14.79M 10-K · filed 2018-07-30 | |
| 2016-04-30 | $12.97M 10-K · filed 2017-07-28 | |
| 2015-04-30 | $9.72M 10-K · filed 2016-07-29 | |
| 2014-04-30 | $5.61M 10-K · filed 2015-07-29 | |
| 2013-04-30 | $4.14M 10-K · filed 2014-07-28 | |
| 2012-04-30 | $2.48M 10-K · filed 2013-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |